SVCM

Saturn V Capital Management Portfolio holdings

AUM $247M
This Quarter Return
+2.13%
1 Year Return
+2.68%
3 Year Return
5 Year Return
10 Year Return
AUM
$121M
AUM Growth
Cap. Flow
+$121M
Cap. Flow %
100%
Top 10 Hldgs %
69.16%
Holding
19
New
19
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRNX icon
1
Crinetics Pharmaceuticals
CRNX
$2.92B
$11.3M 9.41% +623,819 New +$11.3M
TSVT
2
DELISTED
2seventy bio
TSVT
$9.89M 8.2% +684,996 New +$9.89M
APLS icon
3
Apellis Pharmaceuticals
APLS
$3.48B
$9.41M 7.81% +212,329 New +$9.41M
ARQT icon
4
Arcutis Biotherapeutics
ARQT
$1.86B
$8.79M 7.29% +487,179 New +$8.79M
CYTK icon
5
Cytokinetics
CYTK
$4.23B
$7.97M 6.62% +196,982 New +$7.97M
ASND icon
6
Ascendis Pharma
ASND
$11.8B
$7.95M 6.6% +68,404 New +$7.95M
MORF
7
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7.37M 6.12% +269,827 New +$7.37M
ITOS icon
8
iTeos Therapeutics
ITOS
$7.03M 5.83% +342,071 New +$7.03M
ALBO
9
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$6.86M 5.7% +341,827 New +$6.86M
KDNY
10
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$6.73M 5.58% +423,177 New +$6.73M
KALV icon
11
KalVista Pharmaceuticals
KALV
$678M
$6.7M 5.56% +719,937 New +$6.7M
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
$5.72M 4.75% +1,611,778 New +$5.72M
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.68M 4.71% +69,170 New +$5.68M
SAGE
14
DELISTED
Sage Therapeutics
SAGE
$5.37M 4.45% +156,085 New +$5.37M
FOLD icon
15
Amicus Therapeutics
FOLD
$2.34B
$4.89M 4.06% +566,179 New +$4.89M
BCRX icon
16
BioCryst Pharmaceuticals
BCRX
$1.74B
$3.75M 3.11% +340,163 New +$3.75M
BIIB icon
17
Biogen
BIIB
$19.4B
$2.17M 1.8% +7,660 New +$2.17M
ATXS icon
18
Astria Therapeutics
ATXS
$349M
$1.56M 1.29% +169,493 New +$1.56M
TBPH icon
19
Theravance Biopharma
TBPH
$699M
$1.33M 1.11% +141,339 New +$1.33M